Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that new data for four approved medicines and three pipeline candidates in more than 15 types of cancer will be presented at the European Society…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the Phase 3 KEYNOTE-671 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, as a perioperative treatment regimen for patients with resectable stage II, IIIA or IIIB (T3-4N2)…
Rosies Base LLC, a start-up R&D company developing bio-compatible, durable, and cost-effective nano-structured alloys that are ideal for use in cutting-edge medical devices, today announced the appointment of Paul Birkmeyer, MEM, as commercial advisor. An executive and leader at innovative…
Viseon Inc. announces the company is expanding their addressable market beyond minimally invasive spine surgery to focus on several additional market segments where both open and minimally invasive surgery can benefit clinically as well as economically from the Viseon technology,…
AcuityMD, provider of a novel commercial platform for medical technology (MedTech) companies, announced that Intellijoint Surgical, developer of surgical planning and navigation solutions for total hip and knee joint replacements, will leverage its platform to identify new business prospects, manage pipeline, and…
VUZE Medical, a privately-held company aiming to transform intra-operative guidance in minimally invasive spinal interventions, has submitted a 510(k) filing with the U.S. Food and Drug Administration (FDA) for VUZE 2.0, its second generation VUZE System. The new, investigational version of…
BPGbio, Inc., a leading AI-powered biopharma that focuses on oncology, neurology, and rare diseases, today announced plans to present on their groundbreaking AI-developed therapeutics portfolio at the upcoming Pharma Partnering Summit in Boston October 19-20, 2023. At the meeting, BPGbio’s President and…
Noom for Work, Noom’s digital enterprise unit, announced the expansion of its offering to include access to Noom Med, a clinical obesity management solution. With growing employee and member demand for obesity support and anti-obesity medications, the commercial offering for Noom Med…
AUGS PFD Week 2023— Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, commends leading researchers in women’s health, who presented data showing that urinary incontinence (UI) symptom relief is durable for two-years following eight-weeks of…
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB) (“Anebulo”), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (“ACI”), today announced that Richie Cunningham has been appointed as Anebulo’s Chief Executive Officer, replacing Simon Allen. “Anebulo has positioned ANEB-001…
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced its Board of Directors has appointed J. Christopher Barry to the Board, effective today. Barry will serve on the Audit and Compliance Committee. Andrea Saia, who has served as a…
GE HealthCare (Nasdaq: GEHC) today announced its Venue Family point-of-care ultrasound systems will now feature Caption Guidance, artificial intelligence (AI)-driven technology that provides real-time guidance to users for capturing diagnostic-quality cardiac images. The Venue Family is the first among GE…